Valdes, Alberto published the artcileMetabolomics study of COVID-19 patients in four different clinical stages, Computed Properties of 621-37-4, the publication is Scientific Reports (2022), 12(1), 1650, database is CAplus and MEDLINE.
SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is the coronavirus strain causing the respiratory pandemic COVID-19 (coronavirus disease 2019). To understand the pathobiol. of SARS-CoV-2 in humans it is necessary to unravel the metabolic changes that are produced in the individuals once the infection has taken place. The goal of this work is to provide new information about the altered biomol. profile and with that the altered biol. pathways of patients in different clin. situations due to SARS-CoV-2 infection. This is done via metabolomics using HPLC-QTOF-MS anal. of plasma samples at COVID-diagnose from a total of 145 adult patients, divided into different clin. stages based on their subsequent clin. outcome (25 neg. controls (non-COVID); 28 pos. patients with asymptomatic disease not requiring hospitalization; 27 pos. patients with mild disease defined by a total time in hospital lower than 10 days; 36 pos. patients with severe disease defined by a total time in hospital over 20 days and/or admission at the ICU; and 29 pos. patients with fatal outcome or deceased). Moreover, follow up samples between 2 and 3 mo after hospital discharge were also obtained from the hospitalized patients with mild prognosis. The final goal of this work is to provide biomarkers that can help to better understand how the COVID-19 illness evolves and to predict how a patient could progress based on the metabolites profile of plasma obtained at an early stage of the infection. In the present work, several metabolites were found as potential biomarkers to distinguish between the end-stage and the early-stage (or non-COVID) disease groups. These metabolites are mainly involved in the metabolism of carnitines, ketone bodies, fatty acids, lysophosphatidylcholines/phosphatidylcholines, tryptophan, bile acids and purines, but also omeprazole. In addition, the levels of several of these metabolites decreased to “normal” values at hospital discharge, suggesting some of them as early prognosis biomarkers in COVID-19 at diagnose.
Scientific Reports published new progress about 621-37-4. 621-37-4 belongs to alcohols-buliding-blocks, auxiliary class Carboxylic acid,Benzene,Phenol,Natural product, name is 3-Hydroxyphenylacetic acid, and the molecular formula is C20H19NO4, Computed Properties of 621-37-4.
Referemce:
https://en.wikipedia.org/wiki/Alcohol,
Alcohols – Chemistry LibreTexts